Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.

Saved in:
Bibliographic Details
Title: Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021.
Authors: Danpanichkul P; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA., Duangsonk K; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Chen VL; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, Michigan, USA., Saokhieo P; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Dejvajara D; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Sukphutanan B; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Aboona MB; Department of Medicine, University of Arizona College of Medicine - Phoenix, Phoenix, USA., Lopimpisuth C; Department of Internal Medicine, University of Miami/Jackson Memorial Hospital, Miami, Florida, USA., Pang Y; Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China.; National Immunological Laboratory of Traditional Chinese Medicine, Baise, Guangxi, China.; Center for Medical Laboratory Science, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China., Ibrahim AF; Texas Tech University Health Sciences Center, Lubbock, Texas, USA., Fallon MB; Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, Arizona, USA., Huang DQ; Department of Medicine, Division of Gastroenterology and Hepatology, National University Hospital, Singapore, Singapore., Kim D; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA., Singal AG; Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA., Yang JD; Karsh Division of Gastroenterology and Hepatology, Comprehensive Transplant Center, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Aqel BA; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Phoenix, Arizona, USA., Terrault NA; Department of Medicine, Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, California, USA., Wijarnpreecha K; Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, Arizona, USA.; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, Arizona, USA.; BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
Source: Hepatology (Baltimore, Md.) [Hepatology] 2025 Nov 01; Vol. 82 (5), pp. 1274-1286. Date of Electronic Publication: 2025 Feb 11.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3350
DOI:10.1097/HEP.0000000000001260